ask="N/A"
ask_size="N/A"
average_daily_volume="974992"
bid="47.52"
bid_size="300"
book_value="10.71"
change="+2.30"
change_from_200_day_moving_average="3.14"
change_from_50_day_moving_average="7.95"
change_from_52_week_high="-27.87"
change_From_52_week_low="20.86"
change_in_percent="+4.61%"
close="52.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.08"
eps_estimate_next_quarter="-1.31"
eps_estimate_next_year="-4.67"
ex_dividend_date="N/A"
float_shares="71077000"
high="52.32"
high_52_weeks="80.11"
last_trade_date="3/8/2017"
last_trade_price="52.24"
last_trade_size="46575"
last_trade_time="4:00pm"
low="49.64"
low_52_weeks="31.38"
market_capitalization="4.49B"
moving_average_200_day="49.10"
moving_average_50_day="44.29"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="66.07"
open="50.04"
pe_ratio="N/A"
peg_ratio="-0.21"
percent_change_from_200_day_moving_average="+6.40%"
percent_change_from_50_day_moving_average="+17.96%"
percent_change_from_52_week_high="-34.79%"
percent_change_from_52_week_low="+66.48%"
previous_close="49.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.66"
price_per_sales="91.09"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.31"
stock_exchange="NMS"
symbol="ALNY"
volume="932253"
weeks_range_52="31.38 - 80.11"
